← Leaderboards
Baerbel Rohrer
Ralph H Johnson Va Medical Center
$9,101,055
Attributed
$11,693,337
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,693,337 · 9
VA$0 · 3
By mechanism
R01$10,302,369 · 6
P01$972,823 · 1
R03$410,008 · 1
M01$8,137 · 1
I01$0 · 2
IK6$0 · 1
Top collaborators
- John Patterson Atkinson4 shared
- Dwight E Stambolian4 shared
- Dongeun Huh2 shared
Most similar at Ralph H Johnson Va Medical Center
Same institution · by research overlap
- Stephen Tomlinson$13,528,891
Others in their field
Top investigators on “Pathology”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Paul S. Aisen · Cognition Therapeutics, Inc.$155,099,919
- Reisa A. Sperling · Banner Health$154,825,070
- Ronald T Mitsuyasu · University Of California Los Angeles$145,092,412
- Joseph E Robertson · Oregon Health & Science University$126,125,279
Research focus
PathologyComplement ActivationAge Related Macular DegenerationComplementInflammationCellsBlindnessPathway InteractionsDesignChoroidal NeovascularizationAnimal ModelAmericanBasePathologicRisk FactorsMouse ModelS Basal Membrane StructureBruch&AposSiteMonolayerPrevalenceSmokingRetinaSmoke
Grant awards (64)
Assessment of the Complement Pathway in a RPE/choroid Tissue Chip$1,013,515
R01 · FY2025 · EY · contact PI
Functional Analysis of Complement Variants in a Genotyped iPSC Epithelial Cell Model System$749,831
R01 · FY2025 · AI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2025 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Assessment of the Complement Pathway in a RPE/choroid Tissue Chip$1,053,441
R01 · FY2024 · EY · contact PI
Functional Analysis of Complement Variants in a Genotyped iPSC Epithelial Cell Model System$813,267
R01 · FY2024 · AI
Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration$334,312
R01 · FY2024 · EY · contact PI
RPE Cell Bystander Effects Contribute to AMD Pathology$0
I01 · FY2024 · VA · contact PI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2024 · VA · contact PI
BLR&D Research Career Scientist Award for Dr. Barbel Rohrer$0
IK6 · FY2024 · VA · contact PI
Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration$334,312
R01 · FY2023 · EY · contact PI
RPE Cell Bystander Effects Contribute to AMD Pathology$0
I01 · FY2023 · VA · contact PI
BLR&D Research Career Scientist Award for Dr. Barbel Rohrer$0
IK6 · FY2023 · VA · contact PI
Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration$324,281
R01 · FY2022 · EY · contact PI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2022 · VA · contact PI
RPE Cell Bystander Effects Contribute to AMD Pathology$0
I01 · FY2022 · VA · contact PI
BLR&D Research Career Scientist Award for Dr. Barbel Rohrer$0
IK6 · FY2022 · VA · contact PI
Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration$324,283
R01 · FY2021 · EY · contact PI
Sex and Gender Supplement to Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration$150,263
R01 · FY2021 · EY · contact PI
RPE Cell Bystander Effects Contribute to AMD Pathology$0
I01 · FY2021 · VA · contact PI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2021 · VA · contact PI
BLR&D Research Career Scientist Award for Dr. Barbel Rohrer$0
IK6 · FY2021 · VA · contact PI
Elastase and Elastin Peptide Activity in Age-Related Macular Degeneration$403,909
R01 · FY2020 · EY · contact PI
BLR&D Research Career Scientist Award for Dr. Barbel Rohrer$0
IK6 · FY2020 · VA · contact PI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2020 · VA · contact PI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2020 · VA · contact PI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2019 · VA · contact PI
RPE Cell Bystander Effects Contribute to AMD Pathology$0
I01 · FY2019 · VA · contact PI
RPE Cell Bystander Effects Contribute to AMD Pathology$0
I01 · FY2018 · VA · contact PI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2017 · VA · contact PI
RPE Cell Bystander Effects Contribute to AMD Pathology$0
I01 · FY2017 · VA · contact PI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2017 · VA · contact PI
ECT Implants for Factor H Delivery in Models of AMD$370,939
R01 · FY2016 · EY · contact PI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2016 · VA · contact PI
RPE Cell Bystander Effects Contribute to AMD Pathology$0
I01 · FY2016 · VA · contact PI
ECT Implants for Factor H Delivery in Models of AMD$363,519
R01 · FY2015 · EY · contact PI
Complement Factor H-based Therapeutic Strategies in Macular Degeneration$0
I01 · FY2015 · VA · contact PI
ECT Implants for Factor H Delivery in Models of AMD$383,314
R01 · FY2014 · EY · contact PI
Alternative Pathway of Complement Activation in Age-Related Macular Degeneration$311,183
R01 · FY2014 · EY · contact PI
Complement Factor H Haplotypes and Smoking in Age-Related Macular Degeneration$0
I01 · FY2014 · VA · contact PI
Complement Factor H Haplotypes and Smoking in Age-Related Macular Degeneration$0
I01 · FY2014 · VA · contact PI
Complement Factor H Haplotypes and Smoking in Age-Related Macular Degeneration$0
I01 · FY2014 · VA · contact PI
Alternative Pathway of Complement Activation in Age-Related Macular Degeneration$301,656
R01 · FY2013 · EY · contact PI
Alternative Pathway of Complement Activation in Age-Related Macular Degeneration$528,347
R01 · FY2012 · EY · contact PI
Alternative Pathway of Complement Activation in Age-Related Macular Degeneration$317,533
R01 · FY2012 · EY · contact PI
Alternative Pathway of Complement Activation in Age-Related Macular Degeneration$317,533
R01 · FY2011 · EY · contact PI
Complement Factor H Haplotypes and Smoking in Age-Related Macular Degeneration$0
I01 · FY2011 · VA · contact PI
Alternative Pathway of Complement Activation in Age-Related Macular Degeneration$326,489
R01 · FY2010 · EY · contact PI
CORE--ANIMAL$235,883
P01 · FY2009 · AG · contact PI
CORE--ANIMAL$225,391
P01 · FY2008 · AG · contact PI
CORRELATION ANALYSIS BETWEEN THE INCIDENCE OF ALZHEIMER'S DISEASE AND AGE$8,137
M01 · FY2008 · RR · contact PI
CORE--ANIMAL$218,145
P01 · FY2007 · AG · contact PI
CORE--ANIMAL$148,234
P01 · FY2006 · AG · contact PI
CORE--ANIMAL$145,170
P01 · FY2005 · AG
Transgenic Rod Development and Function$141,007
R03 · FY2005 · EY
ROD NEURODEGENERATIVE AND PROTECTIVE GENES$73,000
R01 · FY2005 · EY
ROD NEURODEGENERATIVE AND PROTECTIVE GENES$250,250
R01 · FY2004 · EY
Transgenic Rod Development and Function$133,776
R03 · FY2004 · EY
ROD NEURODEGENERATIVE AND PROTECTIVE GENES$411,662
R01 · FY2003 · EY
ROD NEURODEGENERATIVE AND PROTECTIVE GENES$250,250
R01 · FY2003 · EY
Transgenic Rod Development and Function$135,225
R03 · FY2003 · EY
ROD NEURODEGENERATIVE AND PROTECTIVE GENES$286,000
R01 · FY2002 · EY
ROD NEURODEGENERATIVE AND PROTECTIVE GENES$35,750
R01 · FY2002 · EY
ROD NEURODEGENERATIVE AND PROTECTIVE GENES$273,530
R01 · FY2001 · EY